相关实验视频

Updated: Sep 16, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K

第一线奥西默提尼布治疗EGFR突变状细胞肺癌:一个病例报告

Yugo Matsumura1, Seiya Ichihara1, Kaori Nii1

  • 1Department of Respiratory Medicine, National Hospital Organization Kochi Hospital, Kochi, Japan.

Cancer reports (Hoboken, N.J.)
|July 7, 2025
PubMed
概括

一个罕见的表皮细胞肺癌病例,具有表皮生长因子受体 (EGFR) 突变,对 osimertinib 治疗产生了积极反应. 这一发现表明,osimertinib可能是这个特定患者群体的可行选择.

关键词:
在EGFR的突变.欧洲粮农基金-TKIL858RR 在线播放奥西米尔丁尼布 (osimertinib) 是一种状细胞肺癌是一种肺癌.

更多相关视频

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.0K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K